blog

Analyze Investigator Resources When Recruiting for Rare Disease

By Maria Cipicchio on Wed, Jul 1, 2015 | 3 min read

As we discussed in part I of our blog series on adaptive patient recruitment, the rare disease community is constantly striving to invest in developing new treatments. While there is a huge unmet need in this area, there are recruitment tactics that effectively provide support. Beyond the introduction of an early support program, which Jaime Cohen discussed in our previous post, there are additional strategies that can assist in higher recruitment numbers for rare disease. In part II of our series on rare disease we explore further.

Topics: Patient Recruitment, Rare Disease

Content Marketing Strategies to Support Patient Recruitment

By Jay Housman on Thu, Jun 25, 2015 | 3 min read

The average person spends nearly 4.4 hours of leisure time in front of screens each day. People are online, on their phones or using their tablets in increasing amounts. Given this statistic, it seems natural for there to be a shift from native advertising to content marketing. It’s best to reach consumers where they already are and to push relevant content to them directly to pique interest.

Topics: Patient Recruitment, Content Marketing

MassBio Forum Insights: Clinical Trials in the Age of Social Media

By Aaron Fleishman on Tue, Jun 23, 2015 | 3 min read

We know that social media usage is up year-over-year across all ages, but how is it being put to use for clinical research? On June 11th I had the pleasure of participating in a social media forum hosted by MassBio with PatientsLikeMe, Biogen and Boston Children’s Hospital. It was an eye opening discussion that looked at the use of social media within clinical trials from the varying perspectives of advocacy groups, IRBs and pharmaceutical companies, each with different goals in mind and facing their own set of unique challenges.

Topics: Patient Recruitment, Social Media

Adaptive Patient Recruitment for Rare Disease: Early Support is Key

By BBKWorldwide on Wed, Jun 3, 2015 | 3 min read

There is a huge unmet need in the rare disease community to invest in developing treatments. According to the US advocacy group Global Genes, there are more than 7,000 distinct rare diseases affecting 350,000,000 people worldwide and only 400 approved therapies. How can we adapt traditional recruitment strategies to target the right patients? The goal is to create tailored adaptive strategies aimed at extending reach and building relationships. There are many ways in which this can be done. In this first post of a series focused on adaptive recruitment for rare disease, I will explore the introduction of an early support program.

Topics: Patient Recruitment, Rare Disease

Site Selection & Enrollment Feasibility for Global Patient Recruitment

By BBKWorldwide on Tue, May 12, 2015 | 3 min read

While the push for sponsors to go global with clinical studies is old news, the industry has been working hard to develop and invest in ways to choose the right sites and countries. Ultimately, site selection matters because investigator sites are the only place where study volunteers can participate in clinical research. Enrollment is the end game – further drug development, regulatory submissions and marketing are contingent on having this data.

Topics: Patient Recruitment, Site Selection

Tuning Into Online Streaming Radio

By Justin Jones on Wed, Apr 15, 2015 | 3 min read

Over 100 million people subscribe to streaming radio services such as Pandora® and Spotify®, a number that’s only expected to grow in the years ahead. With the vast majority of those users embracing the ad-supported “freemium” model in over 50 countries around the world, streaming radio represents 
one of the most attractive and cost-effective platforms to connect with global healthcare consumers.

Topics: Patient Recruitment, advertising

Adaptive Marketing Gets to the Heart of Patient Recruitment

By Justin Jones on Thu, Mar 26, 2015 | 2 min read

At BBK we’re often talking about adaptive recruitment and the importance of modifying traditional approaches to increase patient enrollment and retention. Developing an overarching branding strategy for a clinical trial is one of the first steps in a patient recruitment campaign and it’s not a one size fits all approach. BBK has worked on thousands of campaigns over the years, many of which target patients in various countries. There is a lot of diversity to consider when developing the right clinical study branding strategy. Multiple languages, differing philosophies on sensitive topics that may be taboo to discuss publicly in some countries, and varying regulatory environments mean branding must take a strategic and thoughtful approach.

Topics: Patient Recruitment, Branding and Advertising

“Focus 5” - Raise Your Clinical Trial’s Patient Centricity Profile

By BBK Worldwide on Wed, Mar 11, 2015 | 2 min read

BBK Worldwide is pleased to offer our first “Focus 5”, a compilation of quick tips, advice and insights to help companies understand patient centricity as it relates to enhanced patient recruitment and patient engagement within clinical trials.

Topics: Patient Recruitment, Patient Engagement, Patient Centricity

Three Challenges to Implementing Social Media Into Your Patient Recruitment Campaign

By Aaron Fleishman on Fri, Jul 11, 2014 | 4 min read

Considering a social media campaign for your clinical trial? While there are proven advantages to using social media as a patient recruitment tactic, additional considerations must be explored when deciding if social media fits your campaign’s needs. First, scope out your audience by evaluating the opportunity with a social media listening program. For example, how active and engaged is this study community on social media? Or, how many Facebook groups, outlets, etc. are out there for these patients to find each other? Next, evaluate the outlet – What are all my options when building a social media page? Or, what outlets can I use if I just want to advertise?

Topics: BBK Worldwide, Patient Recruitment, Social Media, Technology

FDA Proposes Social Media Guidelines. Sort of.

By Aaron Fleishman on Thu, Jul 10, 2014 | 3 min read

A few weeks ago, and nearly five years after its open hearing on the topic, the Food and Drug Administration (FDA) finally released its proposed guidelines for how drug and device makers should navigate social media. Much has been written on the new guidelines including a few informative posts by Ed Silverman at the Wall Street Journal. As Silverman notes, among the 50 largest drug makers, half are still not using social media to engage consumers or patients, according to a survey by the IMS Institute for Health Informatics. He also suggests that the FDA will likely use the guidances as trial-and-error blueprints themselves as they run across questions that were not answered or situations that may not have been anticipated.

Topics: BBK Worldwide, Patient Recruitment, Social Media, Technology

 
Subscribe To Our Blog